Derville OShea
Overview
Explore the profile of Derville OShea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dudley A, OShea D, Fanning N, Bermingham N, Sweeney B, Cronin S
Pract Neurol
. 2025 Jan;
PMID: 39773778
No abstract available.
2.
Millar S, Mohamed M, Mykytiv V, McMorrow R, Donnelly C, OLeary E, et al.
Ir J Med Sci
. 2024 Jul;
193(6):2615-2623.
PMID: 39030463
Background: The Blood Cancer Network Ireland and National Cancer Registry Ireland worked to create an Enhanced Blood Cancer Outcomes Registry (EBCOR). Enhanced data in acute myeloid leukaemia (AML) included an...
3.
Pallin N, OConnor M, Gannon A, Browne J, Cahill M, OShea D
Eur J Oncol Nurs
. 2023 Jul;
66:102378.
PMID: 37506608
Purpose: Supporting self-management is one strategy to help cancer survivors optimise their quality of life. Low grade non-Hodgkin's lymphoma is often incurable with a chronic disease trajectory requiring lifelong self-management....
4.
Catherwood M, Wren D, Chiecchio L, Cavalieri D, Donaldson D, Lawless S, et al.
Front Oncol
. 2022 Jul;
12:909615.
PMID: 35837095
Limited data exists to show the correlation of (tumour protein 53) mutation detected by Next generation sequencing (NGS) and the presence/absence of deletions of 17p13 detected by FISH. The study...
5.
Crampe M, Kearney L, OBrien D, Bacon C, OShea D, Langabeer S
Case Rep Hematol
. 2019 Jul;
2019:9635070.
PMID: 31346481
Monitoring transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is a widely adopted method to assess response to therapy. However, a small minority of Ph+ ALL...
6.
Mhaolcatha S, Flynn A, Hayes B, OShea D, Bennett M, Fitzgibbon J
Am J Dermatopathol
. 2018 Oct;
41(5):378-381.
PMID: 30371512
Chronic lymphoproliferative disorder of natural killer cells (CLPDNK) is a rare heterogenous indolent disorder comprising a persistent peripheral blood cell count of more than ≥2 × 10/L natural killer cells...
7.
Crampe M, Haslam K, Groarke E, Kelleher E, OShea D, Conneally E, et al.
Case Rep Hematol
. 2017 Nov;
2017:9071702.
PMID: 29123930
A minority of chronic myeloid leukemia patients (CML) express a variety of atypical fusion variants and, of these, the e6a2 fusion is generally associated with an aggressive disease course. Progression...
8.
Haslam K, Conneally E, Flynn C, Cahill M, Gilligan O, OShea D, et al.
Hematol Oncol Stem Cell Ther
. 2016 Jun;
9(3):112-5.
PMID: 27352261
Insertion and/or deletion mutations of the CALR gene have recently been demonstrated to be the second most common driver mutations in the myeloproliferative neoplasms (MPNs) of essential thrombocythemia (ET) and...
9.
Okosun J, Bodor C, Wang J, Araf S, Yang C, Pan C, et al.
Nat Genet
. 2013 Dec;
46(2):176-181.
PMID: 24362818
Follicular lymphoma is an incurable malignancy, with transformation to an aggressive subtype representing a critical event during disease progression. Here we performed whole-genome or whole-exome sequencing on 10 follicular lymphoma-transformed...
10.
OShea D, ORiain C, Gupta M, Waters R, Yang Y, Wrench D, et al.
Blood
. 2009 Jan;
113(10):2298-301.
PMID: 19141865
Acquired homozygosity in the form of segmental acquired uniparental disomy (aUPD) has been described in follicular lymphoma (FL) and is usually due to mitotic recombination. SNP array analysis was performed...